BriaCell Therapeutics Corp.

NASDAQ: BCTX
Nasdaq Stock Market
Healthcare Biotechnology
Global Rank
#39768
Country Rank
#1372
Market Cap
12.88 M
Price
7.63
Change (%)
4.52%
Volume
27,870

BriaCell Therapeutics Corp.'s latest marketcap:

12.88 M

As of 08/29/2025, BriaCell Therapeutics Corp.'s market capitalization has reached $12.88 M. According to our data, BriaCell Therapeutics Corp. is the 39768th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 12.88 M
Revenue (ttm) 0
Net Income (ttm) -19,434,662
Shares Out 1.76 M
EPS (ttm) -83.18
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 10/28/2025
Market Cap Chart
Data Updated: 08/29/2025

BriaCell Therapeutics Corp.'s yearly market capitalization.

BriaCell Therapeutics Corp. has seen its market value drop from $127.3 M to $12.88 M since 2021, representing a total decrease of 89.88% and an annual compound decline rate (CAGR) of 46.50%.
Date Market Cap($) Change (%) Global Rank
08/29/2025 $12.88 M -77.6% 39768
12/31/2024 $25 M -73.26% 32724
12/29/2023 $93.5 M 37.91% 23498
12/30/2022 $67.8 M -46.74% 24813
12/31/2021 $127.3 M 21558

Company Profile

BriaCell Therapeutics Corp. was founded in 2014 in Canada. on the Nasdaq Stock Market. With 16 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.